Susan Dent
苏珊·登特
MD, FRCPC
Professor of Medicine, Director of Cardio-Oncology Program医学教授，肿瘤心脏病学项目主任
👥Biography 个人简介
Professor and Director of Cardio-Oncology at Duke University, Dr. Dent is a world authority on cardiac toxicity of HER2-targeted therapies in breast cancer. She led the SAFE-HEaRt trial and has shaped international guidelines for cardiac monitoring.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
SAFE-HEaRt Trial
Led SAFE-HEaRt trial, enabling HER2-therapy continuation with cardiac dysfunction under optimized cardioprotection management.
International HER2 Cardio-Oncology Guidelines
Developed international cardio-oncology guidelines for HER2-targeted therapy cardiac monitoring, adopted globally.
Duke Cardio-Oncology Program
Built Duke Cardio-Oncology Program integrating oncology and cardiology for comprehensive survivorship care.
Representative Works 代表性著作
SAFE-HEaRt: Treating Patients with HER2-Positive Breast Cancer and Reduced LVEF
JACC: CardioOncology (2019)
Demonstrated safety of continuing HER2 therapy with optimized cardiac management in compromised patients.
Cardiotoxicity of HER2-Targeted Therapies: Current Status and Future Directions
Journal of Clinical Oncology (2016)
Comprehensive review guiding cardiac monitoring in HER2-positive breast cancer treatment.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Bonnie Ky
Penn Medicine / University of Pennsylvania
Javid Moslehi
University of California San Francisco (UCSF)
Richard Steingart
Memorial Sloan Kettering Cancer Center
Daniel Lenihan
International CardiOncology Society (ICOS)
关注 苏珊·登特 的研究动态
Follow Susan Dent's research updates
留下邮箱，当我们发布与 Susan Dent（Duke University Medical Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment